Glenn J. Lesser

10.1k total citations · 2 hit papers
211 papers, 5.2k citations indexed

About

Glenn J. Lesser is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Glenn J. Lesser has authored 211 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Genetics, 67 papers in Pulmonary and Respiratory Medicine and 67 papers in Oncology. Recurrent topics in Glenn J. Lesser's work include Glioma Diagnosis and Treatment (101 papers), Brain Metastases and Treatment (43 papers) and Cancer Treatment and Pharmacology (24 papers). Glenn J. Lesser is often cited by papers focused on Glioma Diagnosis and Treatment (101 papers), Brain Metastases and Treatment (43 papers) and Cancer Treatment and Pharmacology (24 papers). Glenn J. Lesser collaborates with scholars based in United States, United Kingdom and Canada. Glenn J. Lesser's co-authors include George D. Rose, Stuart A. Grossman, Richard Lee, Micheal H. Zehfus, Serena Desideri, Tracy T. Batchelor, Steven Piantadosi, Xiaobu Ye, Edward G. Shaw and Michael D. Chan and has published in prestigious journals such as Science, Journal of Clinical Oncology and Blood.

In The Last Decade

Glenn J. Lesser

199 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hydrophobicity of Amino Acid Residues in Globular Proteins

1985 948 citations Glenn J. Lesser et al. profile →
Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide

2011 413 citations Stuart A. Grossman, Xiaobu Ye et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Glenn J. Lesser

Since Specialization

Citations

This map shows the geographic impact of Glenn J. Lesser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn J. Lesser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn J. Lesser more than expected).

Fields of papers citing papers by Glenn J. Lesser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn J. Lesser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn J. Lesser. The network helps show where Glenn J. Lesser may publish in the future.

Co-authorship network of co-authors of Glenn J. Lesser

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn J. Lesser. A scholar is included among the top collaborators of Glenn J. Lesser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn J. Lesser. Glenn J. Lesser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Muscle quality during cancer treatment and associations with health-related quality of life 2026 ·Quality of Life Research ·(unknown), (unknown), Arnethea L. Sutton, (unknown), (unknown), Glenn J. Lesser, (unknown), (unknown), (unknown), (unknown)	0
2	Impact of an Electronic Patient-Reported Outcome–Informed Clinical Decision Support Tool on Clinical Discussions With Head and Neck Cancer Survivors: Findings From the HN-STAR Randomized Controlled Trial (WF-1805CD) 2025 ·JCO Oncology Practice ·Talya Salz, Emily V. Dressler, Carol Kittel, Andrew Salner, Deborah K. Mayer, Chandylen L. Nightingale, Ryan T. Hughes, Anuja Kriplani, Thomas M. Atkinson, Sujata Patil, Kevin C. Oeffinger, (unknown), (unknown), (unknown), (unknown), Glenn J. Lesser, Jamie S. Ostroff, Kathryn E. Weaver	0
3	Black-White Disparities in Submaximal Exercise Capacity Reductions in Breast Cancer Survivors 2024 ·JACC CardioOncology ·Kerryn W. Reding, (unknown), Ralph B. D’Agostino, Nathaniel S. O’Connell, Alexi Vasbinder, Moriah P. Bellissimo, (unknown), Vanessa B. Sheppard, Arnethea L. Sutton, Bonnie Ky, Glenn J. Lesser, (unknown)	1
4	Factorial Trial to Optimize an Internet-Delivered Intervention for Sexual Health After Breast Cancer: Protocol for the WF-2202 Sexual Health and Intimacy Enhancement (SHINE) Trial 2024 ·JMIR Research Protocols ·Kelly M. Shaffer, Jennifer Barsky Reese, Emily V. Dressler, (unknown), Wendy Cohn, Shayna L. Showalter, Anita H. Clayton, Suzanne C. Danhauer, (unknown), (unknown), (unknown), Kathryn E. Weaver, Glenn J. Lesser, Lee M. Ritterband	1
5	Acupuncture for Chronic Radiation-Induced Xerostomia in Head and Neck Cancer 2024 ·JAMA Network Open ·Lorenzo Cohen, Suzanne C. Danhauer, (unknown), Emily V. Dressler, David I. Rosenthal, Mark S. Chambers, (unknown), W. Mark Brown, (unknown), Peiying Yang, Joseph S. Chiang, (unknown), (unknown), Jung K. Kim, (unknown), (unknown), Mercedes Porosnicu, Kathleen J. Yost, Kathryn E. Weaver, Glenn J. Lesser	8
6	Hypertension Severity and Declines in Left Ventricular Ejection Fraction Among Women Receiving Adjuvant Chemotherapy for Breast Cancer (WF-97415 UPBEAT) 2024 ·Hypertension ·(unknown), Ralph B. D’Agostino, Nathaniel S. O’Connell, Glenn J. Lesser, Fadi N. Salloum, Anika L Hines, Giselle C. Meléndez, Jennifer H. Jordan, Bonnie Ky, Lynne I. Wagner, Arnethea L. Sutton, Wendy Bottinor, Kristine C. Olson, Amy C. Ladd, W. Gregory Hundley, (unknown)	0
7	Statins Do Not Significantly Affect Oxidative Nitrosative Stress Biomarkers in the PREVENT Randomized Clinical Trial 2024 ·Clinical Cancer Research ·Igor Makhlin, Biniyam G. Demissei, Ralph B. D’Agostino, W. Gregory Hundley, Camelia Baleanu‐Gogonea, Nicholas S. Wilcox, (unknown), Amanda M. Smith, Nathaniel S. O’Connell, James L. Januzzi, Glenn J. Lesser, Marielle Scherrer‐Crosbie, Borja Ibáñez, W.H. Wilson Tang, Bonnie Ky	6
8	Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116) 2024 ·Journal of Clinical Oncology ·Stephen R. Rapp, Emily V. Dressler, W. Mark Brown, James L. Wade, Nguyet Le‐Lindqwister, David M. King, Kendrith M. Rowland, Kathryn E. Weaver, Heidi D. Klepin, Edward G. Shaw, Glenn J. Lesser	9
9	Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastoma 2024 ·Neuro-Oncology Advances ·Samuel Ryu, Xiaobu Ye, Jeffrey J. Olson, Tom Mikkelsen, Lev Bangiyev, Glenn J. Lesser, Tracy T. Batchelor, Burt Nabors, Serena Desideri, Tobias Walbert, Stuart A. Grossman	4
10	IMMU-22. BLOCKADE OF CD47 RESULTS IN METABOLIC REPROGRAMMING TO ENHANCE IMMUNE CELL-MEDIATED CYTOTOXICITY OF GLIOBLASTOMA 2023 ·Neuro-Oncology ·Yu-Ting Tsai, Glenn J. Lesser, David R. Soto‐Pantoja	1
11	Management of Thromboembolic Disease in Patients with Primary and Metastatic Brain Tumors 2023 ·Current Treatment Options in Oncology ·(unknown), Glenn J. Lesser	1
12	HSP90-CDC37 functions as a chaperone for the oncogenic FGFR3-TACC3 fusion 2022 ·Molecular Therapy ·Tao Li, Farideh Mehraein‐Ghomi, M. Elizabeth Forbes, (unknown), (unknown), Qianqian Song, Ping‐Chieh Chou, Xuya Wang, Brittany C. Parker Kerrigan, Frederick F. Lang, Glenn J. Lesser, Waldemar Debinski, Xuejun Yang, Wei Zhang	11
13	A Review on the Surgical Management of Insular Gliomas 2021 ·Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ·Jaclyn J. Renfrow, (unknown), Desmond Brown, Stephen B. Tatter, Adrian W. Laxton, Glenn J. Lesser, Roy E. Strowd, Ian F. Parney	3
14	Capacity to Provide Geriatric Specialty Care for Older Adults in Community Oncology Practices 2020 ·The Oncologist ·Grant R. Williams, Kathryn E. Weaver, Glenn J. Lesser, Emily V. Dressler, Karen M. Winkfield, Heather B. Neuman, Anne E. Kazak, Ruth C. Carlos, (unknown), Charles Kamen, Joseph M. Unger, Supriya G. Mohile, Heidi D. Klepin	27
15	Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor 2020 ·Scientific Reports ·Jaclyn J. Renfrow, M. Soike, James L. W. West, Shakti Ramkissoon, Linda J. Metheny‐Barlow, Ryan T. Mott, Carol Kittel, Ralph B. D’Agostino, Stephen B. Tatter, Adrian W. Laxton, Mark B. Frenkel, Gregory A. Hawkins, Denise Herpai, Stephanie Sanders, Jann N. Sarkaria, Glenn J. Lesser, Waldemar Debinski, Roy E. Strowd	23
16	Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study 2019 ·Human Genomics ·Eunkyung Lee, Cristiane Takita, Jean L. Wright, Susan H. Slifer, Eden R. Martin, James J. Urbanic, Carl D. Langefeld, Glenn J. Lesser, Edward G. Shaw, Jennifer J. Hu	18
17	Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44 2018 ·Cancer Research ·Tadas Rimkus, Richard L. Carpenter, Sherona Sirkisoon, Dongqin Zhu, Boris Pasche, Michael D. Chan, Glenn J. Lesser, Stephen B. Tatter, Kounosuke Watabe, Waldemar Debinski, Hui‐Wen Lo	32
18	National Institute on Aging /Alzheimer’s Association criteria for Mild Cognitive Impairment applied to chemotherapy treated breast cancer survivors 2017 ·PubMed ·(unknown), Julia Lawrence, Laura D. Baker, Ernie Balcueva, Doug Case, Suzanne Craft, (unknown), Leah Griffin, (unknown), Heidi D. Klepin, Glenn J. Lesser, Michael J. Messino, Michelle J. Naughton, Thomas A. Samuel, Steve Rapp, Bonnie C. Sachs, Kaycee M. Sink, Jeff D. Williamson, Edward G. Shaw	7
19	Randomized Trial to Assess the Impact of Venlafaxine and Soy Protein on Hot Flashes and Quality of Life in Men With Prostate Cancer 2013 ·Journal of Clinical Oncology ·Mara Z. Vitolins, Leah Griffin, (unknown), Jacqueline Vuky, Paul T. Adams, (unknown), Bart Frizzell, Glenn J. Lesser, Michelle Naughton, James E. Radford, Edward G. Shaw	32
20	The in vitro cytotoxic and radiation sensitizing effects of docetaxel (Taxotere) and a novel taxane RPR116258 on Glioblastoma cell lines 2005 ·Cancer Research ·Suzanne M. Hess, (unknown), (unknown), Joel G. Anderson, A. William Blackstock, Glenn J. Lesser	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact